Johns Hopkins Bloomberg School of Public Health
 Bookmark and Share
   
Primary Container Roundtable
Experts to gather to examine vaccine container decisions in low- and middle-income countries More
National Vaccine Summit in Nigeria
National Vaccine Summit in Nigeria
IVAC partners with Nigerian health and political leaders to hold vaccine summit More
Estimated Economic Benefits During The Decade Of Vaccines
Estimated Economic Benefits During The Decade Of Vaccines
New IVAC research estimates the potential economic benefits during the "Decade of Vaccines:" an estimated 6.4 million child deaths could be averted while saving $145 billion dollars. More
Largest Global Childhood Pneumonia Etiology Study Launched
Largest Global Childhood Pneumonia Etiology Study Launched
In a collaboration between 5 African and 2 Asian research sites coordinated by IVAC, this landmark study will examine current and likely future causes of childhood pneumonia. More
Why is Coke available in villages around Timbuktu, but not antibiotics?
Why is Coke available in villages around Timbuktu, but not antibiotics?
A new report from IVAC asks why products like Coca Cola can reach remote villages in developing nations while essential medicines like antibiotics cannot always be found. More

PERCH Special Supplement in Clinical Infectious Disease

In a new publication, IVAC outlines new insight and understanding into one of the largest studies ever conducted on the causes of pneumonia among children in the developing world. For more information on this landmark PERCH publication, please click here.

Connect With Us

Subscribe to the IVAC newsletter, Focus on Vaccine Access:

Latest Updates

   
interest